Abstract
The mouse has long been an important component of cancer research. From the realization by Little and Bagg early days of the past century demonstrating a heritable component of sponanteous cancer to the oncogenic manipulations of the germline today, the mouse has been and will continue to be the major mammalian in vivo system to study neoplasic transformation and progression. Use of the mouse has pervaded almost every aspect of cancer research, including discovery of oncogenes, analysis of tumor suppressors, development of novel therapeutic strategies, and exploring the mutagenic effects of chemicals and ionizing radiation, to name a few. The development over the last twenty years of transgenic, homologous recombination and conditional-transgenic or knockout technologies has enormously expanded the breadth and scope of the mouse in cancer research and has contributed significantly to our understanding of the events that lead up to and accompany neoplastic transformation. Although there are significant limitations of modeling human cancers in the mouse, these proven technologies as well as technologies currently under development, will continue to provide experimentally tractable systems in which to explore the genetic and molecular events of cancer initiation and progression. As a result, the mouse as a model for human neoplastic disease will continue to have a significant place in the experimental toolbox of cancer researchers for many years to come.
Keywords: Neoplastic transformation, cancer research, tumor suppressor, oncogenes, conditional transgenic, testicular tumors, pharmacokinetics, virally induced, xenograft system, chemical carcinogenesis, transgenics
Current Genomics
Title: The Mouse In Cancer Research Past, Present, Future
Volume: 2 Issue: 1
Author(s): K. Hunter and D. Cozma
Affiliation:
Keywords: Neoplastic transformation, cancer research, tumor suppressor, oncogenes, conditional transgenic, testicular tumors, pharmacokinetics, virally induced, xenograft system, chemical carcinogenesis, transgenics
Abstract: The mouse has long been an important component of cancer research. From the realization by Little and Bagg early days of the past century demonstrating a heritable component of sponanteous cancer to the oncogenic manipulations of the germline today, the mouse has been and will continue to be the major mammalian in vivo system to study neoplasic transformation and progression. Use of the mouse has pervaded almost every aspect of cancer research, including discovery of oncogenes, analysis of tumor suppressors, development of novel therapeutic strategies, and exploring the mutagenic effects of chemicals and ionizing radiation, to name a few. The development over the last twenty years of transgenic, homologous recombination and conditional-transgenic or knockout technologies has enormously expanded the breadth and scope of the mouse in cancer research and has contributed significantly to our understanding of the events that lead up to and accompany neoplastic transformation. Although there are significant limitations of modeling human cancers in the mouse, these proven technologies as well as technologies currently under development, will continue to provide experimentally tractable systems in which to explore the genetic and molecular events of cancer initiation and progression. As a result, the mouse as a model for human neoplastic disease will continue to have a significant place in the experimental toolbox of cancer researchers for many years to come.
Export Options
About this article
Cite this article as:
Hunter K. and Cozma D., The Mouse In Cancer Research Past, Present, Future, Current Genomics 2001; 2 (1) . https://dx.doi.org/10.2174/1389202013351165
DOI https://dx.doi.org/10.2174/1389202013351165 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Recent Patents on Cardiovascular Drug Discovery Targeting the SUMO E2 Conjugating Enzyme Ubc9 Interaction for Anti-Cancer Drug Design
Anti-Cancer Agents in Medicinal Chemistry Airway Remodeling: Effect of Current and Future Asthma Therapies
Current Respiratory Medicine Reviews Pharmacological Modulation of p53 Function in Cancer Therapy
Current Signal Transduction Therapy Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Current Neurovascular Research Rb at the Interface Between Cell Cycle and Apoptotic Decisions
Current Molecular Medicine Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Recent Patents Relating to Tumor Suppressor Genes
Recent Patents on DNA & Gene Sequences Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology DNA Methylation in Colon Cancer: Challenges and Opportunities
Epigenetic Diagnosis & Therapy (Discontinued) Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets Chemoprevention of Colorectal Carcinogenesis by Natural Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols
Current Pharmaceutical Biotechnology Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
Current Medicinal Chemistry Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Current Progress of Reelin in Development, Inflammation and Tissue Remodeling: From Nervous to Visual Systems
Current Molecular Medicine Current or New Cytomegalovirus Antivirals and Novel Animal Model Strategies
Inflammation & Allergy - Drug Targets (Discontinued) The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Family of Proteins: Transcriptional Modifiers with Multi-Functional Protein Interfaces
Current Molecular Medicine Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
Current Gene Therapy